Chimeric Therapeutics is trading 25% up now at A$0.01, with no clear company-specific announcement identified to explain the move.
- Recent seven-day closes repeatedly moved between A$0.00 and A$0.01, so the rise is occurring at a very low share price.
- The latest listed filing is a September 22 securities quotation application; the August trial-enrolment halt is earlier context, not an established cause.
- Supplied market indices were flat, so broader-market direction does not explain the move.